Journal profile · SUBSTANCE ABUSE-PSYCHIATRY
European Addiction Research
ISSN 1022-6877 · eISSN 1421-9891 · S. Karger AG · SWITZERLAND · Founded 1995
European Addiction Research: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 1.93; hybrid open access; median 181 days to acceptance (57 articles, last 24 months); community-reported acceptance: fairly easy; 31 articles in 2025; indexed in SCIE, SSCI and Scopus.
Scope
Aims, scope and focus
European Addiction Research is published by S. Karger AG and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment and Human auditory perception and evaluation, together about 41.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
European Addiction Research is a unique international scientific journal for the rapid publication of innovative research covering all aspects of addiction and related disorders. Representing an interdisciplinary forum for the exchange of recent data and expert opinion, it reflects the importance of a comprehensive approach to resolve the problems of substance abuse and addiction in Europe. Coverage ranges from clinical and research advances in the fields of psychiatry, biology, pharmacology, and epidemiology to social and legal implications of policy decisions. The goal is to facilitate open discussion among those interested in the scientific and clinical aspects of prevention, diagnosis, and therapy as well as dealing with legal issues.
From the journal's Aims & Scope
Research area (LetPub): SUBSTANCE ABUSE-PSYCHIATRY
Editor-in-chief Karen D. ErschePublisher website
Editorial board by country: none in mainland China; most named United Kingdom 2, Switzerland 2, United States 1, Canada 1, Netherlands 1 (9 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Substance Abuse Treatment and OutcomesMedicine24.2%
- Opioid Use Disorder TreatmentMedicine10.6%
- Human auditory perception and evaluationEngineering6.5%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance6.2%
- HIV, Drug Use, Sexual RiskMedicine5.9%
- Alcohol Consumption and Health EffectsMedicine5%
- Forensic Toxicology and Drug AnalysisPharmacology, Toxicology and Pharmaceutics4.7%
- Smoking Behavior and CessationMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Psychiatry | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
| Minor | Psychiatry | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Psychiatry | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIESSCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.93LetPub ·
- Impact factor (publisher)
- 1.8Publisher website ·
- CiteScore 2026-06
- 4.5LetPub ·
- CiteScore (publisher)
- 4.5Publisher website ·
- SJR 2026-06
- 0.76LetPub ·
- SNIP 2026-06
- 1.02LetPub ·
- h-index
- 48LetPub ·
- h-index
- 79OpenAlex ·
- i10-index
- 711OpenAlex ·
- 2-year mean citedness
- 1.63OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 69.61%LetPub ·
Volume
- Articles per year
- 27LetPub ·
Articles by year OpenAlex count · 1,370 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 26 | 26 | 6 |
| 2025 | 31 | 30 | 29 |
| 2024 | 44 | 30 | 130 |
| 2023 | 51 | 38 | 257 |
| 2022 | 47 | 31 | 487 |
| 2021 | 52 | 29 | 712 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
181 daysMedian, submission to acceptance · P25–P75 128 days – 224 days
- Acceptance to online
- median 11 days (57 articles)
- Submission to online
- median 192 days
- Sample
- 57 articles with submission and acceptance dates (65 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to final decision
- 70 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers3, by deadline
Publisher websitePolicy excerpts from the journal's websiteOpen access
- Open access
2026 volume fully Open Access via Subscribe to Open (S2O); no charges to authors. Model summary
The 2026 volume of European Addiction Research is fully Open Access and authors can publish without any charges. European Addiction Research is a Subscribe to Open (S2O) journal, aiming to achieve Open Access without cost to authors or readers.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- S. Karger AG
- Country or region
- SWITZERLAND
- Language
- English
- Founded
- 1995
- ISSN
- 1022-6877
- Electronic ISSN
- 1421-9891
- Latest issue on the website
- Volume 32, Issue 3 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about European Addiction Research
What CAS zone is European Addiction Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Addiction Research is in Zone 3 of Medicine, and in Zone 3 of the minor category Psychiatry / Substance Abuse. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Addiction Research?
The latest impact factor listed by LetPub is 1.93; CiteScore 4.5, h-index 79.
How long does peer review take at European Addiction Research?
Based on the dates recorded on 57 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 181 days (interquartile range 128–224 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of European Addiction Research based?
Of the 9 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (2), Switzerland (2) and United States (1). Counted from the institutions listed on the board page; for reference only.
Which databases index European Addiction Research?
According to LetPub and DOAJ records, European Addiction Research is indexed in SCIE, SSCI and Scopus.
Is European Addiction Research open access, and what is the APC?
European Addiction Research is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .